Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Ciba Health

start up
United States - New York, New York
  • 09/05/2024
  • Series A
  • $10,000,000

Ciba Health is revolutionizing the care and treatment of chronic and metabolic disease conditions, through a patient-centered, root cause approach and a value-based care delivery model. We provide full spectrum integrated care and convenient access to multi-disciplinary care team, leveraging cutting edge technology to implement each patient's personalized and whole-person care treatment plan.


Related People

Innocent C.Founder

Innocent C. United States - New York, New York

Innocent Clement is a physician, innovator, and entrepreneur, He is the founder and CEO of Ciba Health, a company that revolutionizes the care and treatment of chronic and metabolic diseases, such as pre-diabetes, obesity, and type 2 diabetes, through a patient-centered, root cause approach and a value-based care delivery model.

Before launching Ciba Health, Innocent was the co-founder and CEO of Kaia Health, a digital therapeutic company that uses artificial intelligence and computer vision to create medicines that silence or turn off the genes that cause or contribute to disease. He led the company's initiatives in the US, including partnerships, clinical trials, regulatory submissions, and expansion across North America. He is also a board member at CUNY Graduate School of Public Health and Health Policy, where he contributes his expertise and vision to advance public health education and research. Innocent is passionate about using technology and innovation to improve health outcomes and quality of life for people with chronic and metabolic conditions.